| Toggle Summary
|
MediWound to Host Third Quarter 2014 Financial Results Conference Call on November 5, 2014 at 4:30 p.m. Eastern Time
|
View HTML
|
| Toggle Summary
|
MediWound's NexoBrid to be Featured at International Society for Burn Injuries 2014
Multiple Oral and Poster Presentations Highlight NexoBrid's Innovative, Effective and Fast Enzymatic Debriding of Severe Burns
|
View HTML
|
| Toggle Summary
|
MediWound Reports Second Quarter 2014 Financial Results
Conference Call Begins Today at 8:30 a.m. Eastern Time
|
View HTML
|
| Toggle Summary
|
MediWound to Host Second Quarter 2014 Financial Results Conference Call on July 31, 2014 at 8:30 a.m.
|
View HTML
|
| Toggle Summary
|
MediWound Announces NexoBrid Marketing Approval From Israeli Ministry of Health
Market Launch Planned for This Quarter
|
View HTML
|
| Toggle Summary
|
MediWound to Present at Jefferies 2014 Global Healthcare Conference
|
View HTML
|
| Toggle Summary
|
MediWound Expands Distribution of NexoBrid to South Korea Through Agreement With BexPharm Korea
|
View HTML
|
| Toggle Summary
|
MediWound Initiates Second Phase 2 Clinical Trial of EscharEx(TM) to Treat Chronic and Other Hard-to-Heal Wounds
Trial to Build Upon Earlier Study With Encouraging Outcomes in Poorly Served Multibillion-Dollar Market
|
View HTML
|
| Toggle Summary
|
MediWound Announces Successful GMP Manufacturing Audit by the Israeli Ministry of Health
|
View HTML
|
| Toggle Summary
|
MediWound Completes Recruitment of Commercial Management Team in Europe
Expanding Commercial and R&D Leadership
|
View HTML
|
